Investors/Media

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need. Learn more about our clinical pipeline here.

Corporate Presentation

Stock Information

Change

High

Minimum 15 minutes delayed. Source:

Events and Presentations

September 10, 2024 at 4:30 PM EDT
H.C. Wainwright 26th Annual Global Investment Conference Sign up
May 15, 2024 at 8:30 AM EDT
2024 RBC Capital Markets Global Healthcare Conference Sign up
May 14, 2024 at 10:30 AM EDT
The JMP Securities Life Sciences Conference Sign up